Literature DB >> 33289603

Synthesis, biochemical evaluation and molecular modeling studies of nonpeptidic nitrile-based fluorinated compounds.

Rafael da Fonseca Lameiro1, Anwar Shamim1, Fabiana Rosini1, Rodrigo Cendron1, Pedro Henrique Jatai Batista1, Carlos Alberto Montanari1.   

Abstract

Aim: Compounds that block enzyme activity can kill pathogens and help develop effective and safe drugs for Chagas disease and leishmaniasis. Materials & methods: A library of nonpeptidic nitrile-based compounds was synthesized and had their inhibitory affinity tested against cruzain, Leishmania mexicana cysteine protease B and cathepsin L. Isothermal titration calorimetry experiments and molecular simulations were performed for selected compounds to obtain thermodynamic fingerprints and identify main interactions and putative modes of binding with cruzain.
Results: The derivatives provided increased affinity against all enzymes compared with the lead, and thermodynamic and computational studies showed improved thermodynamic properties and a possible different mode of binding.
Conclusion: Our studies culminated in 1b, a compound 60-fold more potent in cruzain than its lead that also showed entropic and enthalpic contributions favorable to Gibbs binding energy.

Entities:  

Keywords:  LmCPB; cathepsin L; cruzain; cysteine proteases; fluorine; nonpeptidic; structure–activity relationship (SAR)

Year:  2020        PMID: 33289603     DOI: 10.4155/fmc-2020-0057

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  2 in total

Review 1.  Computational approaches towards the discovery and optimisation of cruzain inhibitors.

Authors:  Viviane Corrêa Santos; Rafaela Salgado Ferreira
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-16       Impact factor: 2.743

Review 2.  Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases.

Authors:  Simone Brogi; Roberta Ibba; Sara Rossi; Stefania Butini; Vincenzo Calderone; Sandra Gemma; Giuseppe Campiani
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.